[This corrects the article DOI: 10.18632/oncotarget.21981.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324690 | PMC |
| http://dx.doi.org/10.18632/oncotarget.26489 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bridging the educational gaps of health professionals in oncogenomics: results from a pilot e-learning course.
Front Med (Lausanne)
November 2024
Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
Article Synopsis
- The effectiveness of a pilot e-learning course on oncogenomics for health professionals was assessed, revealing significant knowledge gains.
- Nearly 350 Italian professionals, primarily physicians, showed an average post-test score that increased by 19% after completing the course, with older age and southern region residency linked to larger improvements.
- Participants rated the course highly in terms of methodology, content quality, and usability, indicating strong satisfaction and potential for broader use in professional education.
Enhancing RNA-seq analysis by addressing all co-existing biases using a self-benchmarking approach with 2D structural insights.
Brief Bioinform
September 2024
Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Nanshan District, Shenzhen, 518055, China.
We introduce a groundbreaking approach: the minimum free energy-based Gaussian Self-Benchmarking (MFE-GSB) framework, designed to combat the myriad of biases inherent in RNA-seq data. Central to our methodology is the MFE concept, facilitating the adoption of a Gaussian distribution model tailored to effectively mitigate all co-existing biases within a k-mer counting scheme. The MFE-GSB framework operates on a sophisticated dual-model system, juxtaposing modeling data of uniform k-mer distribution against the real, observed sequencing data characterized by nonuniform k-mer distributions.
View Article and Find Full Text PDFAuthor Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.
Nat Immunol
November 2024
Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing.
Am J Clin Nutr
September 2024
Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States; Department of Epidemiology, University of Washington, Seattle, WA, United States.
Article Synopsis
- Folate intake plays a crucial role in genetic and metabolic processes, and low levels are linked to higher cancer risk, specifically colorectal cancer (CRC).
- The study analyzed dietary and supplemental folate intake among participants with CRC, investigating how this intake relates to specific genetic mutations using advanced sequencing techniques.
- Results indicated that higher total folate intake generally reduced CRC risk, but the impact varied when considering mutation status in tumors, with a few specific gene mutations showing different associations with folate intake.
Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities.
Cell Discov
March 2024
Oncogenomic and Epigenetic Unit, Italian National Cancer Institute 'Regina Elena', Rome, Italy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!